APA (7th ed.) Citation

Rini, B., Mariani, M., Pietro, A. d., Nathan, P., Kollmannsberger, C., Grimm, M., . . . Chen, Y. Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: Post hoc analyses from the JAVELIN Renal 101 trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Rini, Brian, et al. Association Between Neutrophil-to-eosinophil Ratio and Efficacy Outcomes with Avelumab Plus Axitinib or Sunitinib in Patients with Advanced Renal Cell Carcinoma: Post Hoc Analyses from the JAVELIN Renal 101 Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Rini, Brian, et al. Association Between Neutrophil-to-eosinophil Ratio and Efficacy Outcomes with Avelumab Plus Axitinib or Sunitinib in Patients with Advanced Renal Cell Carcinoma: Post Hoc Analyses from the JAVELIN Renal 101 Trial. BMJ Publishing Group.